Natera, Inc. (NTRA) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Diagnostics & Research secteur d'activité. Le siège social de l'entreprise est situé à Austin, CA, United States. Le PDG actuel est Steven Leonard Chapman.
NTRA a date d'introduction en bourse 2015-07-01, 4,424 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $30.42B.
Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services globally, serving the reproductive health, oncology, and transplant markets. Its core portfolio includes Panorama, a non-invasive prenatal test for chromosomal abnormalities; Horizon, a carrier screening test for genetic diseases; Spectrum, which identifies genetic conditions during in vitro fertilization; Anora, a miscarriage analysis test; and Signatera, a circulating tumor DNA technology for cancer screening and monitoring. The company also offers Constellation, a cloud-based software platform that enables laboratory partners to access its proprietary algorithms and bioinformatics. Natera commercializes its products through a direct sales force and a network of approximately 100 laboratory and distribution partners, supported by strategic partnerships with BGI Genomics and Foundation Medicine. Founded in 2003 and based in Austin, Texas, the company continues to expand its diagnostic capabilities across multiple clinical applications.
